AzTrials
AzTrials

ObesityNCT00064961

Obesity Prevention After Smoking Cessation in Menopause

A study testing Weight-management and smoking cessation maintenance and Smoking Cessation program in people with Obesity and Menopause, run by National Institute on Aging (NIA) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study addresses the high risk of weight gain associated with smoking cessation in women. The obesity prevention pilot study is designed for the primary prevention of weight gain that can lead to overweight in normal-weight women, that can progress to obesity in women who are already overweight, and for the… Read more about this study

Who is it for?
Ages 45 to 59 years, women onlyHealthy volunteers can take part
Conditions the study is for
Obesity, Menopause
What is being tested?
Weight-management and smoking cessation maintenance and Smoking Cessation program
How many people
100 participants
Where
1 siteUnited States
Study dates
Mar 2000to Feb 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 59 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Female aged 45 - 59 at time of enrollment
  • African-American or Caucasian; able to confirm racial heritage of past two generations in family
  • Postmenopausal
  • Smokers (more than 10 cigarettes per day for 1 year or more)
  • Written physician approval to participate in program and medical clearance that use of over-the-counter nicotine replacement is not contraindicated based on patient's medical status

Who cannot join

  • Men
  • Age below 45 or above 59
  • Nonsmokers
  • Currently in a standardized weight-reduction program or taking medications for weight loss
  • History or presence of significant psychiatric illness (e.g., eating disorders, psychosis, psychoactive substance abuse, major depression)
  • History of presence of severe physical illness (e.g., renal failure, hepatic failure, cancer, immunological disease)
  • Unable to complete long-term study commitment, including anticipating moving out of study area prior to completion of the study
  • Unable to confirm racial heritage of past two generations in family.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • LSU Pennington Biomedical Research Center

    Baton Rouge, Louisiana, 70808

Other trials in United States

About this study

This study addresses the high risk of weight gain associated with smoking cessation in women. The obesity prevention pilot study is designed for the primary prevention of weight gain that can lead to overweight in normal-weight women, that can progress to obesity in women who are already overweight, and for the prevention of additional weight gain in obese women with BMI greater than or equal to 30.0. Fat and other macronutrient intake, specifically, sugar, complex carbohydrates, and protein, are analyzed as a target for individually tailored, weight control intervention following smoking cessation in Caucasian and African American women.

Read the detailed description

Middle-aged women, especially African Americans, who quit smoking are at high risk for weight gain, overweight, and obesity. Postcessation weight gain has been attributed to increased food intake, which in turn, has been ascribed to a selective increase in high-sugar and other high-carbohydrate foods with a high-fat content. This study compares the relative effectiveness, for postmenopausal Caucasian and African American women, of following an empirically validated smoking cessation program with either 1) a group cessation maintenance program with standard exercise advice and food pyramid instructions for healthy eating or 2) an individually tailored, dietary-control, exercise, weight-management and cessation-maintenance program. Effectiveness is assessed by weight change from baseline to postcessation months 6, 12, and 20.

The second aim is to assess overall fat and other specific macronutrient intake (sugar, complex carbohydrates, and protein) and total caloric intake with the use of a novel macronutrient self-selection paradigm in Caucasian and African-American postmenopausal women at baseline prior to smoking cessation, after being abstinent for one week, and again at 6, 12, and 20 months postcessation.

The third aim is to assess whether there is differential responsiveness on the above measures in postmenopausal Caucasian vs. African-American women.

Conditions
Obesity, Menopause
Being tested
Individualized dietary-control and exercise program, Weight-management and smoking cessation maintenance, Smoking Cessation program
Keywords
Smoking Cessation
Medical subject headings
Obesity, Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Individualized dietary-control and exercise programBehavioural

  • Weight-management and smoking cessation maintenanceBehavioural

  • Smoking Cessation programBehavioural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2003 (estimated)
  2. Study startMar 2000
  3. Primary completionFeb 2006
  4. Study completionFeb 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Intervention model
Parallel groups
Masking
Single blind
Enrolment
100 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00064961
Sponsor's protocol ID
AG0004
Status last verified
Dec 2009
First submitted
16 Jul 2003
Last updated
11 Dec 2009
Results posted
No

Publications

  • Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami D, Allen S, Lando H. Smoking cessation in women concerned about weight. Am J Public Health. 1992 Sep;82(9):1238-43. doi: 10.2105/ajph.82.9.1238.

    PubMed 1503165
  • Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med. 1991 Mar 14;324(11):739-45. doi: 10.1056/NEJM199103143241106.

    PubMed 1997840
  • Hall SM, Tunstall CD, Vila KL, Duffy J. Weight gain prevention and smoking cessation: cautionary findings. Am J Public Health. 1992 Jun;82(6):799-803. doi: 10.2105/ajph.82.6.799.

    PubMed 1585959
  • Heymsfield SB, Gallagher D, Poehlman ET, Wolper C, Nonas K, Nelson D, Wang ZM. Menopausal changes in body composition and energy expenditure. Exp Gerontol. 1994 May-Aug;29(3-4):377-89. doi: 10.1016/0531-5565(94)90018-3.

    PubMed 7925757
  • Geiselman PJ, Anderson AM, Dowdy ML, West DB, Redmann SM, Smith SR. Reliability and validity of a macronutrient self-selection paradigm and a food preference questionnaire. Physiol Behav. 1998 Mar;63(5):919-28. doi: 10.1016/s0031-9384(97)00542-8.

    PubMed 9618017

Questions about this trial

What is this clinical trial studying?

A study testing Weight-management and smoking cessation maintenance and Smoking Cessation program in people with Obesity and Menopause, run by National Institute on Aging (NIA) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Dec 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00064961, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in